אולנזאפין דקסל 5 מ"ג

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

OLANZAPINE 5 MG

Dostępny od:

DEXCEL PHARMA TECHNOLOGIES LTD

Kod ATC:

N05AH03

Forma farmaceutyczna:

TABLETS

Droga podania:

PER OS

Wyprodukowano przez:

DEXCEL LTD

Grupa terapeutyczna:

OLANZAPINE

Wskazania:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Data autoryzacji:

2012-05-01